MedTrace Logo

Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male Volunteers

NCT01415466 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2012-04-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the pharmacokinetics profile and drug-drug interaction between rosuvastatin and CS-866 in healthy male volunteers.

Conditions

  • Healthy

Interventions

DRUG

Cresto

tablet, 20mg

DRUG

Olmetec

tablet, 40mg

DRUG

Cresto, Olmetec

tablet, 20mg and 40mg

Sponsors & Collaborators

  • Yonsei University

    collaborator OTHER

  • Daewoong Pharmaceutical Co. LTD.

    lead INDUSTRY

Principal Investigators

  • Kyungsoo Park, M.D., Ph.D. · YONSEI UNIVERSITY HEALTH SYSTEM (YUHS)

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2011-09-30
Completion
2011-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01415466 on ClinicalTrials.gov